{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:45:50Z","timestamp":1746333950219},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Major National Basic Research Program of P. R. China","award":["2011CB503904"],"award-info":[{"award-number":["2011CB503904"]}]},{"DOI":"10.13039\/501100001809","name":"the Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81270369, 81070244, 30770873"],"award-info":[{"award-number":["81270369, 81070244, 30770873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Natural Science Foundation","award":["7142060"],"award-info":[{"award-number":["7142060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0186-6","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T04:00:20Z","timestamp":1452657620000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people"],"prefix":"10.1186","volume":"16","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"186_CR1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.nut.2012.09.015","volume":"29","author":"A Chmurzynska","year":"2013","unstructured":"Chmurzynska A, Malinowska AM, Twardowska-Rajewska J, Gawecki J. Elderly women: homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism). Nutrition. 2013;29:841\u20134.","journal-title":"Nutrition"},{"key":"186_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10545-010-9177-4","volume":"34","author":"HJ Blom","year":"2011","unstructured":"Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis. 2011;34:75\u201381.","journal-title":"J Inherit Metab Dis"},{"key":"186_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jjcc.2012.11.009","volume":"61","author":"N Mahalle","year":"2013","unstructured":"Mahalle N, Kulkarni MV, Garg MK, Naik SS. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol. 2013;61:289\u201394.","journal-title":"J Cardiol"},{"key":"186_CR4","doi-asserted-by":"crossref","first-page":"E1061","DOI":"10.1152\/ajpendo.00367.2010","volume":"299","author":"L He","year":"2010","unstructured":"He L, Zeng H, Li F, Feng J, Liu S, Liu J, et al. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia. Am J Physiol Endocrinol Metab. 2010;299:E1061\u20135.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"186_CR5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/jhh.2014.22","volume":"28","author":"J Liu","year":"2014","unstructured":"Liu J, Xu Y, Zhang H, Gao X, Fan H, Wang G. Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia. J Hum Hypertens. 2014;28:743\u20137.","journal-title":"J Hum Hypertens"},{"key":"186_CR6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2004.10.033","volume":"179","author":"G Wang","year":"2005","unstructured":"Wang G, Dai J, Mao J, Zeng X, Yang X, Wang X. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis. 2005;179:395\u2013402.","journal-title":"Atherosclerosis"},{"key":"186_CR7","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1074\/jbc.M112.431627","volume":"288","author":"Y Li","year":"2013","unstructured":"Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng J, et al. Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem. 2013;288:9583\u201392.","journal-title":"J Biol Chem"},{"key":"186_CR8","doi-asserted-by":"crossref","first-page":"C1466","DOI":"10.1152\/ajpcell.00304.2009","volume":"297","author":"C Jiang","year":"2009","unstructured":"Jiang C, Zhang H, Zhang W, Kong W, Zhu Y, Xu Q, et al. Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin. Am J Physiol Cell Physiol. 2009;297:C1466\u201376.","journal-title":"Am J Physiol Cell Physiol"},{"key":"186_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11883-012-0235-2","volume":"14","author":"S Bandeali","year":"2012","unstructured":"Bandeali S, Farmer J. High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Curr Atheroscler Rep. 2012;14:101\u20137.","journal-title":"Curr Atheroscler Rep"},{"key":"186_CR10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCRESAHA.111.300581","volume":"112","author":"T Umemoto","year":"2013","unstructured":"Umemoto T, Han CY, Mitra P, Averill MM, Tang C, Goodspeed L, et al. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1. Circ Res. 2013;112:1345\u201354.","journal-title":"Circ Res"},{"key":"186_CR11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/1479164115579008","volume":"12","author":"J Liu","year":"2015","unstructured":"Liu J, Wang Y, Fan H, Miao L, Zhang H, Wang G. Hyperhomocysteinaemia is associated with low plasma apolipoprotein AI levels in patients with impaired glucose tolerance. Diab Vasc Dis Res. 2015;12:298\u2013301.","journal-title":"Diab Vasc Dis Res"},{"key":"186_CR12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","volume":"98","author":"LG Mikael","year":"2006","unstructured":"Mikael LG, Genest Jr J, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res. 2006;98:564\u201371.","journal-title":"Circ Res"},{"key":"186_CR13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"186_CR14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005344-200310000-00001","volume":"42","author":"R Rodrigo","year":"2003","unstructured":"Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G. Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension. J Cardiovasc Pharmacol. 2003;42:453\u201361.","journal-title":"J Cardiovasc Pharmacol"},{"key":"186_CR15","first-page":"259","volume":"70","author":"A Januszewicz","year":"2012","unstructured":"Januszewicz A. High normal blood pressure - a problem of growing clinical importance. Kardiol Pol. 2012;70:259.","journal-title":"Kardiol Pol"},{"key":"186_CR16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4070\/kcj.2012.42.5.304","volume":"42","author":"NS Yoon","year":"2012","unstructured":"Yoon NS, Jeong MH, Ahn Y, Kim JH, Chae SC, Kim YJ, et al. Impact of high-normal blood pressure measured in emergency room on adverse cardiac events in acute myocardial infarction. Korean Circ J. 2012;42:304\u201310.","journal-title":"Korean Circ J"},{"key":"186_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/jme.0.0270085","volume":"27","author":"S Najib","year":"2001","unstructured":"Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol. 2001;27:85\u201391.","journal-title":"J Mol Endocrinol"},{"key":"186_CR18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","volume":"6","author":"S Tangvarasittichai","year":"2015","unstructured":"Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes. 2015;6:456\u201380.","journal-title":"World J Diabetes"},{"key":"186_CR19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/157016112803520882","volume":"10","author":"M Anselmino","year":"2012","unstructured":"Anselmino M, Sillano D. Impact of pre-diabetes and diabetes on cardiovascular outcomes. Curr Vasc Pharmacol. 2012;10:680\u20133.","journal-title":"Curr Vasc Pharmacol"},{"key":"186_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI6577","volume":"104","author":"HM Dansky","year":"1999","unstructured":"Dansky HM, Charlton SA, Barlow CB, Tamminen M, Smith JD, Frank JS, et al. Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium. J Clin Invest. 1999;104:31\u20139.","journal-title":"J Clin Invest"},{"key":"186_CR21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007111830472","volume":"209","author":"RA Srivastava","year":"2000","unstructured":"Srivastava RA, Srivastava N. High density lipoprotein, apolipoprotein A-I, and coronary artery disease. Mol Cell Biochem. 2000;209:131\u201344.","journal-title":"Mol Cell Biochem"},{"key":"186_CR22","doi-asserted-by":"crossref","first-page":"e78241","DOI":"10.1371\/journal.pone.0078241","volume":"8","author":"KB Holven","year":"2013","unstructured":"Holven KB, Retterstol K, Ueland T, Ulven SM, Nenseter MS, Sandvik M, et al. Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype. PLoS One. 2013;8:e78241.","journal-title":"PLoS One"},{"key":"186_CR23","doi-asserted-by":"crossref","first-page":"L333","DOI":"10.1152\/ajplung.00183.2002","volume":"284","author":"HS Sood","year":"2003","unstructured":"Sood HS, Hunt MJ, Tyagi SC. Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia. Am J Physiol Lung Cell Mol Physiol. 2003;284:L333\u201341.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"186_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1476-511X-10-137","volume":"10","author":"Y Xiao","year":"2011","unstructured":"Xiao Y, Zhang Y, Lv X, Su D, Li D, Xia M, et al. Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects. Lipids Health Dis. 2011;10:137.","journal-title":"Lipids Health Dis"},{"key":"186_CR25","doi-asserted-by":"crossref","first-page":"38188","DOI":"10.1074\/jbc.M306336200","volume":"278","author":"A Morishima","year":"2003","unstructured":"Morishima A, Ohkubo N, Maeda N, Miki T, Mitsuda N. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha. J Biol Chem. 2003;278:38188\u201393.","journal-title":"J Biol Chem"},{"key":"186_CR26","first-page":"718","volume":"2013","author":"A Tlili","year":"1832","unstructured":"Tlili A, Jacobs F, de Koning L, Mohamed S, Bui LC, Dairou J, et al. Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt\/GSK3 pathways in hyperhomocysteinemic mice. Biochim Biophys Acta. 1832;2013:718\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"186_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1476-511X-12-74","volume":"12","author":"E Soderstrom","year":"2013","unstructured":"Soderstrom E, Eliasson M, Johnson O, Hallmans G, Weinehall L, Jansson JH, et al. Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population. Lipids Health Dis. 2013;12:74.","journal-title":"Lipids Health Dis"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0186-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:36:27Z","timestamp":1498275387000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2261\/16\/10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0186-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]},"article-number":"10"}}